Mineralys Therapeutics In... (MLYS)
NASDAQ: MLYS
· Real-Time Price · USD
14.51
0.38 (2.69%)
At close: Aug 15, 2025, 3:59 PM
14.52
0.10%
After-hours: Aug 15, 2025, 04:20 PM EDT
Mineralys Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Net Income | -190.77M | -188.51M | -177.81M | -153.25M | -119.67M | -90.8M | -71.9M | -56.58M | -40.5M | -34.84M | -29.8M | -27.81M | -21.13M | -14.65M | -7.08M |
Depreciation & Amortization | 57K | 50K | 43K | 28K | 17K | 8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 17.34M | 12.79M | 11.34M | 9.66M | 5.23M | 6.5M | 5.06M | 3.82M | 2.44M | 1.19M | 455K | 253K | 61K | 35K | 16K |
Other Working Capital | -18.36M | -7.71M | 9.31M | 25.04M | 23.46M | 5.27M | -7.47M | -4.41M | -8.78M | -261K | -199.89K | 721.26K | 984.26K | 265.00 | 157.00 |
Other Non-Cash Items | 29.8M | 21.29M | 19.83M | 19.1M | -6.51M | -8.52M | -6.87M | -5.21M | -3.49M | -1.5M | -647.1K | -235.08K | 3.92K | 2.88K | 2.02K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -49.11M | -38.28M | -19.71M | -3.98M | 23.64M | 5.27M | -7.47M | -4.41M | -8.78M | -261K | 772K | 3.87M | 4.13M | 3.15M | 2.18M |
Operating Cash Flow | -192.69M | -192.66M | -166.31M | -128.45M | -97.3M | -87.54M | -81.17M | -62.38M | -50.34M | -35.42M | -29.22M | -23.93M | -16.94M | -11.47M | -4.89M |
Capital Expenditures | -37K | -37K | -96K | -96K | -59K | -59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -368.55M | -377.93M | -373.44M | -382.6M | -379.74M | -308.61M | -347.97M | -274.88M | -290.65M | -234.51M | -71.76M | -71.76M | n/a | n/a | n/a |
Sales Maturities Of Investments | 396M | 456M | 488.5M | 406M | 327.5M | 232.5M | 187.5M | 172.5M | 112.5M | 72.5M | 50M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -16.14K | -16.14K | 49.98M | 49.91M | 49.93M | 49.93M | -71.76K | n/a | n/a | n/a |
Investing Cash Flow | 27.42M | 78.03M | 114.96M | 23.3M | -52.3M | -76.17M | -160.47M | -102.38M | -178.15M | -162.01M | -21.76M | -71.76M | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 142K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 126.09M | 116.17M | 116.14M | -6K | -6K | 86K | n/a | -1.07M | -1.07M | -1.07M | -1.07M | n/a | n/a | n/a | n/a |
Financial Cash Flow | 199.2M | 189.22M | 116.14M | 116.13M | 116.31M | 115.88M | 203.25M | 202.11M | 201.36M | 319.59M | 128.02M | 129.09M | 129.65M | 12M | n/a |
Net Cash Flow | 33.93M | 74.59M | 64.79M | 10.97M | -33.28M | -47.83M | -38.4M | 37.34M | -27.12M | 122.17M | 77.04M | 33.4M | 112.71M | 529K | -4.89M |
Free Cash Flow | -192.72M | -192.7M | -166.41M | -128.55M | -97.36M | -87.6M | -81.17M | -62.38M | -50.34M | -35.42M | -29.22M | -23.93M | -16.94M | -11.47M | -4.89M |